Cervical cancer
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1 Aged 20-60 years; 2 Patients with stage IB2, IIA2, IIB cervical cancer; 3 Normal blood analysis, liver and kidney function before treatment; 4 No evidence of distant metastasis; 5 No serious heart, liver, kidney and blood system and other important organ diseases; 6 Patients have signed the informed consent
Exclusion criteria
Exclusion criteria: 1 Early or small lesions do not require neoadjuvant chemotherapy patients; 2 cachexia:PS score = 3 points, KPS score < 70 points; 3 Active infection or bleeding; 4 Complete intestinal obstruction; 5 Uncontrolled psychosis; 6 Pregnant and lactating women; 7 Allergic constitution, or known to arsenic allergy patients; 8 Late no possibility of surgery patients; 9 Patients who are unwilling to receive neoadjuvant chemotherapy combined with surgery in the advanced stage; 10 Patients with severe comorbidities; 11 Patients who cannot tolerate chemotherapy and surgical words; 13 Patients who have participated in other clinical trials in the last 3 months; 12 Any other conditions that the investigator considers unsuitable for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficiency evaluation; | — |
Countries
China
Contacts
Public ContactLi Daocheng
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed